2656.HK · 160 HEALTH
Hong Kong · RS rating 1 · As of 2026-10-14
| Price | 2.82 HKD |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 1 / 1 / 1 / 2 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 2 / 15 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +89.3% |
| Distance from 52-week high | +98.1% |
| Market cap (USD) | $141.4M |